IndexIQ Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,009,016
Closed -$18.2M 1061
2020
Q2
$18.2M Buy
+1,009,016
New +$14M 0.81% 35

IndexIQ Advisors's PTLA Position: Q3 2020 in Review

IndexIQ Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 1,009,016 shares — an estimated $18.2M sold.

IndexIQ Advisors first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $18.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • IndexIQ Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • IndexIQ Advisors sold 1,009,016 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $18.2M.
  • IndexIQ Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • IndexIQ Advisors's Portola Pharmaceuticals, Inc. position peaked at $18.2M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on IndexIQ Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.